Circulating deoxyribonucleic acid as prognostic marker
in non-small-cell lung cancer patients undergoing chemotherapy.
Urokinase plasminogen activator: a prognostic marker
in multiple types of cancer.
NPs are helpful for monitoring disease course and risk stratification in HF patients because they are independent prognostic markers
in HF and myocardial infarction patients.
Various prognostic markers
to assess the severity of AP have been evaluated.
Core to peripheral temperature gradient measurement is a simple and non-invasive technique to assess the state of peripheral circulation and has been reported by the previous studies too as a good indicator of haemodynamic status and prognostic marker
sup],, In cardiac surgery, elevation of PCT has been observed postoperatively in the absence of any evidence of infection and also appears to be a good prognostic marker
Table-I: Evaluation of RA diagnostic and prognostic marker
However, subsequent studies showed that association between mutation status and CD38 expression level was not absolute and that CD38 expression should be considered as an independent prognostic marker
Subsequently, an international Ki-67 in breast cancer working group was set up in 2010 to examine the value of Ki-67 as a reproducible prognostic marker
and to address the problems of methodology.
Chromogranin A is a Potential Prognostic Marker
in Prostate Cancer Patients treated with Enzalutamide.
We believe that the candidate prognostic marker
should be checked to distinguish malignant from benign SFTs.
The present study was conducted to evaluate the role of serum HsCRP as a prognostic marker
in elderly patients presenting with sepsis.
Tumor size is a good prognostic marker
for distant relapse in lymph node negative patients, although patients with small tumors (< 1 cm), left untreated, have approximately a 12% chance of recurrence.
Chromosome 15 trisomies seen as a part of hyperdiploidy were found to be a good prognostic marker
(5), (14), (23).
The main focus has been to determine the patterns of molecular level alterations in p16 gene in human ovarian cancers to explore the possibilities of identifying potential biomarker in blood which could help in clinical practice as a diagnostic and prognostic marker